Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma

Drug Information

Target Indication

Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma

Clinical Trial

Last updated: 2/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

RHHBY

Roche Holding AG

Related Pipeline

Chronic Obstructive Pulmonary Disease (COPD)

Non-Small Cell Lung Cancer

Schizophrenia

Squamous Non-Small Cell Lung Cancer

Lupus Nephritis